Clinical Update - Articles - Page 9

CLINICAL UPDATE

Medications to Treat OCD: What Psychotherapists Need to Know

July 3, 2023

Jessica L Goren, PharmD. Instructor in Psychiatry, Cambridge Health Alliance.

Dr. Goren has no financial relationships with companies related to this material.

Learn about common medications for OCD, including SSRIs and clomipramine, along with their side effects, as well as the role of CBT and augmentation strategies in treatment.

Clinical Update

Are Two Antidepressants Better Than One?

July 3, 2023

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA.

Dr. Posternak has no financial relationships with companies related to this material.

New research calls to question the common practice of antidepressant combinations. Dr. Posternak makes sense of it.

Clinical Update

Auvelity: A Fast-Acting Antidepressant?

July 3, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how to use it and the pros/cons of generic substitution.

CLINICAL UPDATE

How to Advise Clients About Light Therapy

June 30, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Light therapy is an effective treatment for winter and nonseasonal depression as well as other related disorders. To use this therapy, you’ll need to know a few basics.

Clinical Update

A Psychedelic Primer

June 1, 2023

Chris Aiken, MD and Garrett Rossi, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

The authors have no financial relationships with companies related to this material.

How did a dangerous drug of abuse become a therapeutic panacea?

Clinical Update

What Psychiatrists Need to Know About Intravenous Drug Use and Endocarditis

May 29, 2023

Kenechukwu Mezue, MD, MSc and Bernardo Lombo, MD, FACC

Kenechukwu Mezue, MD, MSc. Clinical Fellow in Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.

Bernardo Lombo, MD, FACC. Assistant Professor of Cardiology, Yale School of Medicine, New Haven, CT.

Dr. Mezue and Dr. Lombo have no financial relationships with companies related to this material.

Infective endocarditis (IE) is a dangerous and potentially life-threatening complication of intravenous drug use. This article explores the pathogenesis of IE, key symptoms to recognize, and the crucial steps to take if an infection is suspected.

Clinical Update

Fentanyl Testing: An Emerging Harm Reduction Strategy

May 29, 2023

Noah Capurso, MD and Alyssa Falleni, PharmD

Alyssa Falleni, PharmD. CT Health Education and Research in SUD and Related Harms (CHERISH) Fellow; VA Connecticut Healthcare System, Orange, CT.

Noah Capurso, MD, MHS. Assistant Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief of The Carlat Addiction Treatment Report.

Dr. Falleni and Dr. Capurso have no financial relationships with companies related to this material.

Discover the lifesaving potential of fentanyl test strips (FTS). As fentanyl infiltrates illicit drug markets, FTS offer an essential harm reduction strategy. We’ll explore the technology behind FTS, how to obtain and use them, discuss their legality, and examine their role in preventing opioid overdose deaths.

Clinical Update

Medication Treatments for Alcohol and Opioid Use Disorder in Older Adults

May 11, 2023

Rehan Aziz, MD.

Rehan Aziz, MD. Associate program director, Geriatric Psychiatry Fellowship Program, Jersey Shore University Medical Center, Neptune, NJ; associate professor of psychiatry and neurology, Hackensack Meridian School of Medicine, Nutley, NJ.

Dr. Aziz has no financial relationships with companies related to this material.

With three FDA-approved medications for alcohol use disorders and three FDA-approved medications for opioid use disorders, it can be hard to know where to start. Here we review the pros and cons of these six medications—and provide recommendations for their use in older adults.

Clinical Update

Screening Tools, Assessment, and Brief Interventions for Substance Use Disorders in Older Adults

May 9, 2023

Julia Cromwell, MD

Julia Cromwell, MD. Inpatient geriatric psychiatrist, Mass General Brigham Salem Hospital, Salem, MA.

Dr. Cromwell has no financial relationships with companies related to this material.

How do you choose a screening tool for substance use disorders in older adults, and what do you do when a patient screens positive? We discuss common screening tools, assessments, and interventions based on an older adult’s risk level.

Clinical Update